JLVMX
Price
$22.63
Change
-$0.10 (-0.44%)
Updated
Jun 3 closing price
Net Assets
5.11B
VIVAX
Price
$83.16
Change
-$0.03 (-0.04%)
Updated
Jun 3 closing price
Net Assets
237.83B
Interact to see
Advertisement

JLVMX vs VIVAX

Header iconJLVMX vs VIVAX Comparison
Open Charts JLVMX vs VIVAXBanner chart's image
JLVMX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
JLVMX vs. VIVAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLVMX is a Buy and VIVAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 238B vs. JLVMX (5.11B). VIVAX pays higher dividends than JLVMX: VIVAX (1.76) vs JLVMX (1.31). JLVMX was incepted earlier than VIVAX: JLVMX (16 years) vs VIVAX (34 years). JLVMX (0.49) is less costly to investors than VIVAX (0.17). JLVMX is a more actively managed with annual turnover of: 185.00 vs. VIVAX (8.00). VIVAX has a lower initial minimum investment than JLVMX: VIVAX (0) vs JLVMX (15000000). VIVAX annual gain was more profitable for investors over the last year : 23.68 vs. JLVMX (16.90). VIVAX return over 5 years is better than : 51.49 vs. JLVMX (15.56).
JLVMXVIVAXJLVMX / VIVAX
Total Expense Ratio0.440.17259%
Annual Report Gross Expense Ratio0.490.17288%
Fund Existence16 years34 years-
Gain YTD7.65411.61966%
Front LoadN/AN/A-
Min. Initial Investment150000000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.11B238B2%
Annual Yield % from dividends1.311.7675%
Returns for 1 year16.9023.6871%
Returns for 3 years32.6754.4860%
Returns for 5 years15.5651.4930%
Returns for 10 years97.50152.5964%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JBL379.045.88
+1.58%
Jabil
FF4.27-0.03
-0.70%
Future Fuel Corp
TCBI98.99-0.75
-0.75%
Texas Capital Bancshares
LXU12.81-0.25
-1.91%
LSB Industries
BLRX3.25-0.14
-4.13%
BioLineRx Ltd